Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,335,852
-
Share change
-
+648,081
-
Total reported value
-
$48,442,542
-
Price per share
-
$1.71
-
Number of holders
-
53
-
Value change
-
+$738,192
-
Number of buys
-
20
-
Number of sells
-
28
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q4 2021
As of 31 Dec 2021,
RECRO PHARMA INC - COM (SCTL) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,335,852 shares.
The largest 10 holders included
AWM Investment Company, Inc., Cowen Prime Advisors LLC, Samjo Capital LLC, Athyrium Capital Management, LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Rubric Capital Management LP, STEPHENS INC /AR/, and Russell Investments Group, Ltd..
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.